Second chance: precise radiation aims to tame recurrent prostate cancer
NCT ID NCT03246802
First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times
Summary
This study tests a high-dose radiation implant (brachytherapy) for men whose prostate cancer returned after standard external beam radiation. About 30 participants will receive this targeted treatment to the exact spot of recurrence, identified by advanced MRI. The goal is to control the cancer while limiting side effects, though lifelong monitoring is still needed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
BCCA Center for the Southern Interior
RECRUITINGKelowna, British Columbia, V1Y 5L3, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New PET scan technique could map hidden prostate cancer recurrences
- Immune-Boosting drug and vaccine aim to fight returning prostate cancer
- Could a depression drug fight prostate cancer?
- Scientists dig into prostate Cancer's surroundings for clues
- Can a 2-week drug boost scan accuracy for hidden prostate cancer?
- Light-activated therapy offers new hope for recurrent prostate cancer